Oncolytic viruses exploit tumor-specific molecular changes in cancer cells for their replication, such as p53 deficiency [3], oncogenic Ras activation [3], defects in the type I interferon (IFN)-induced antiviral response [4] and viral receptors uniquely expressed on cancer cells [5]. This evidence concerns the gene TP53 and cancer.